Johan Styrke

13PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer cell biologyProteomics and metabolomicsLiquid biopsiesEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 21, 2026
Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer.

|Apr 27, 2026
Recurrence Rate After Post-Operative Two-Hour Continuous Bladder Irrigation for Primary Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study.

|Mar 31, 2026
Number of risk factors versus infection after transrectal prostate biopsy: a nationwide population-based study.

Joakim Örtegren, Olof Elvstam, Kimia Kohestani

|Sep 03, 2025
Safety and efficacy in Sclerotherapy of testicular hydro/spermatocele with 25 versus 50 mL Ethanol 99.5%; a randomised controlled phase II study.

Sarah Velander, Karl-Johan Lundström, Johan Styrke

|Jan 16, 2025
Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry vs. data from a detailed research database.

Albin Wedholm, Erik Wiberg, Johan Styrke

|Apr 15, 2024
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer.

Pär Stattin, Sarah Fleming, Xiwu Lin

Pageof 3

Frequent Collaborators

4 joint publications

Pär Stattin

2 joint publications

Amir Sherif

2 joint publications

Farhood Alamdari

2 joint publications

Elin Axén